89bio Inc (NASDAQ:ETNB) price on current trading day, rose 14.70% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.54.
A look at the stock’s price movement, the close in the last trading session was $4.83, moving within a range at $4.16 and $5.83. The beta value (5-Year monthly) was 1.291. Turning to its 52-week performance, $11.84 and $4.74 were the 52-week high and 52-week low respectively. Overall, ETNB moved -26.53% over the past month.
89bio Inc’s market cap currently stands at around $808.75 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ETNB is a 100% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 7 recommend ETNB as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ETNB’s current price about -27.06% and -37.81% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.03, while 7-day volatility ratio is 20.65% and 12.21% in the 30-day chart. Further, 89bio Inc (ETNB) has a beta value of 1.63, and an average true range (ATR) of 0.85. Analysts have given the company’s stock an average 52-week price target of $25, forecast between a low of $12 and high of $29. Looking at the price targets, the low is -116.61% off current price level while to achieve the yearly target high, price needs to move -423.47%. Nonetheless, investors will most likely welcome a -351.26% jump to $25 which is the analysts’ median price.
If we refocus on 89bio Inc (NASDAQ:ETNB), historical trading data shows that trading volumes averaged 2.74 over the past 10 days and 2.61 million over the past 3 months. The company’s latest data on shares outstanding shows there are 145.98 million shares.
The 3.88% of 89bio Inc’s shares are in the hands of company insiders while institutional holders own 89.71% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 11.01 million on 2025-03-14, giving us a short ratio of 6.91. The data shows that as of 2025-03-14 short interest in 89bio Inc (ETNB) stood at 898.99994 of shares outstanding, with shares short rising to 9.13 million registered in 2025-02-14. Current price change has pushed the stock -29.16% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ETNB stock continues to rise going into the next quarter.
